BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Lacticaseibacillus rhamnosus {l. rhamnosus} - Escherichia coli KD1 |
👶
Lactobacillus rhamnosus LB1 Alleviates Enterotoxigenic Escherichia coli-Induced Adverse Effects in Piglets by Improving Host Immune Response and Anti-Oxidation Stress and Restoring Intestinal Integrity. Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 11 Issue Pages: 724401 Pub: 2021 Epub: 2021 Nov 2 Authors Wu T , Shi Y , Zhang Y , Zhang M , Zhang L , Ma Z , Zhao D , Wang L , Yu H , Hou Y , Gong J , Html Article Publication |
| Lacticaseibacillus rhamnosus {l. rhamnosus} - Escherichia coli KD1 |
👶
Lactobacillus rhamnosus from human breast milk shows therapeutic function against foodborne infection by multi-drug resistant Escherichia coli in mice. Food & function (Food Funct ) Vol: 11 Issue 1 Pages: 435-447 Pub: 2020 Jan 29 Epub: Authors Li N , Pang B , Liu G , Zhao X , Xu X , Jiang C , Yang B , Liu Y , Shi J , Publication |
| Lacticaseibacillus rhamnosus {l. rhamnosus} - Escherichia coli KD1 |
👶
The effect of Lactobacillus rhamnosus on enterohemorrhagic Escherichia coli infection of human intestinal cells in vitro. Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 405-9 Pub: 2003 Epub: Authors Hirano J , Yoshida T , Sugiyama T , Koide N , Mori I , Yokochi T , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
